Risk Factors Associated with Immunogenicity Testing
Abstract:When it comes to immunogenicity testing of biotech products and derivatives, a number of risk factors have to be considered. This article describes these risk factors and who should consider them during the testing process.
Trending Compliance Trainings
Transfer of Analytical Methods According to the USP Chapter <1224>
By - Dr. Ludwig Huber
On Demand Access Anytime
By - Dr. Ludwig Huber
On Demand Access Anytime
4-Hour Virtual Training: Auditing the Microbiology Laboratory
By - Robert D Seltzer
On Demand Access Anytime
By - Robert D Seltzer
On Demand Access Anytime
Microbiological Risk: Do I Really Need to Test Raw Materials for Microorganisms
By - Henry Urbach
On Demand Access Anytime
By - Henry Urbach
On Demand Access Anytime
You Found an Objectionable Microorganism, Now What? Risk of presence of Objectionable Microorganisms in Biopharmaceuticals
By - Henry Urbach
On Demand Access Anytime
By - Henry Urbach
On Demand Access Anytime
FDA Regulation of Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps)
By - Mukesh Kumar
On Demand Access Anytime
By - Mukesh Kumar
On Demand Access Anytime
Documentation Requirements for Master and Working Cell Banks
By - Debra Barngrover
On Demand Access Anytime
By - Debra Barngrover
On Demand Access Anytime
You Recently Viewed
